CSN Login
Members Online: 5

Trial just started for bone-mestastatic p.cancer in Chicago

Posts: 58
Joined: Sep 2009


Safety and Efficacy Study of KX2-391 in Patients With Bone-Metastatic, Castration-Resistant Prostate Cancer Who Have Not Received Prior Chemotherapy

This study is currently recruiting participants.

Verified by Kinex Pharmaceuticals, LLC, February 2010
First Received: February 22, 2010

Please refer to this study by its ClinicalTrials.gov identifier: NCT01074138

Contact: Laura Dalfonso 716-881-7549 ldalfonso@ahrminc.com
Contact: Lyn Dyster, Ph.D. 716-881-8972 ldyster@kinexpharma.com

United States, Illinois
University of Chicago Recruiting
Chicago, Illinois, United States, 60637
Contact: Beth Manchen, MS, RN 773-702-4135 emanchen@medicine.bsd.uchicago.edu
Principal Investigator: Edwin Posadas, MD

find more info at: http://www.clinicaltrials.gov/ct2/show/NCT01074138

randy_in_indy's picture
Posts: 493
Joined: Oct 2009

This is certainly information someone might really use.

Randy In Indy

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2015 © Cancer Survivors Network